2RQS

3D structure of Pin from the psychrophilic archeon Cenarcheaum symbiosum (CsPin)

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
2	2D 1H-13C HSQC	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
3	2D 1H-1H TOCSY	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
4	3D CBCA(CO)NH	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
5	3D C(CO)NH	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
6	3D HNCO	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
7	3D HNCA	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
8	3D HNCACB	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
9	3D HBHA(CO)NH	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
10	3D 1H-13C NOESY	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289
11	3D 1H-15N NOESY	0.6mM [U-100% 13C; U-100% 15N] CsPin	90% H2O/10% D2O	0.1	7.5	ambient	289

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Varian	Uniform NMR System	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	200
Conformers Submitted Total Number	20
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	geometry optimization	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
2	refinement	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read
3	structure solution	CNS	1.2	Brunger, Adams, Clore, Gros, Nilges and Read

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.